Trending...
- $4.3 Million Patent Application Waiver Fee Granted by FDA on New Drug Application Fee for Treatment Addressing Suicidal Depression & PTSD: NRX Pharma
- New Book 'Cybersecurity Leadership' Guides SME Leaders to Make Smart, Strategic Security Decisions
- Austin Keen Joins WakeFX RopePal as Official Brand Ambassador
SEATTLE ~ AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), has been awarded a special mention for Research and Innovation led by Executives Under the Age of 40 by Confindustria. Confindustria is the main association representing manufacturing and service companies in Italy, with a voluntary membership of more than 150,000 companies of all sizes, employing a total of 5,383,286 people.
The AGC Biologics Milan site has a strong team of life science professionals, with 72% of the workforce being under the age of 40. The site's leadership promotes a dynamic and diverse environment to support these team members in their mission to help pharmaceutical companies bring lifesaving treatments to market. 80% at the site hold college degrees, and among those, 16% have achieved a PhD. 61% of leadership positions are held by women.
Francesco De Santis, Vice President of Confindustria for Research and Development noted that "the award is a recognition of companies that have stood out for the quality of innovation" and that "a national commitment is necessary to go with this process and make the national research, development, and innovation system increasingly integrated".
More on Washingtoner
Luca Alberici from AGC Biologics Milan said "this award showcases the work and potential of our business and the young professionals here in Milan that help make our site so successful". He added that "our entire team is driven by innovation in the workplace and delivering the highest level of quality in our work, to ensure patients get the treatments they need".
AGC Biologics acquired its Milan site (formerly MolMed S.p.A.) to add a cell and gene CDMO business to its offerings in July 2020; it has since become the global hub for their cell and gene therapy services. The team at this site has brought multiple products from pre-clinical through commercial phases as well as developed custom plug-and-play systems for vector manufacturing such as AGC's BravoAAV™ and ProntoLVV™ platforms.
The award from Confindustria recognizes AGC Biologics' commitment to research & development as well as their dedication to providing innovative solutions for their clients while also promoting diversity within their workforce.
The AGC Biologics Milan site has a strong team of life science professionals, with 72% of the workforce being under the age of 40. The site's leadership promotes a dynamic and diverse environment to support these team members in their mission to help pharmaceutical companies bring lifesaving treatments to market. 80% at the site hold college degrees, and among those, 16% have achieved a PhD. 61% of leadership positions are held by women.
Francesco De Santis, Vice President of Confindustria for Research and Development noted that "the award is a recognition of companies that have stood out for the quality of innovation" and that "a national commitment is necessary to go with this process and make the national research, development, and innovation system increasingly integrated".
More on Washingtoner
- Fairmint Introduces First Fully Onchain and Open Cap Table Infrastructure
- Vortex Brands Begins Gold Purchases Under New Joint Venture with Dubai-Based Partner
- Spokane: Early Morning House Fire Leaves One Critically Injured
- NBA Champion Lamar Odom Launches Anti-Addiction Meme Coin, Ushering in a Disruptive Innovation in Web3
- Beaches and Big Cities Remain the Top Travel Destination for American Summer Travelers
Luca Alberici from AGC Biologics Milan said "this award showcases the work and potential of our business and the young professionals here in Milan that help make our site so successful". He added that "our entire team is driven by innovation in the workplace and delivering the highest level of quality in our work, to ensure patients get the treatments they need".
AGC Biologics acquired its Milan site (formerly MolMed S.p.A.) to add a cell and gene CDMO business to its offerings in July 2020; it has since become the global hub for their cell and gene therapy services. The team at this site has brought multiple products from pre-clinical through commercial phases as well as developed custom plug-and-play systems for vector manufacturing such as AGC's BravoAAV™ and ProntoLVV™ platforms.
The award from Confindustria recognizes AGC Biologics' commitment to research & development as well as their dedication to providing innovative solutions for their clients while also promoting diversity within their workforce.
Filed Under: Business
0 Comments
Latest on Washingtoner
- Robert Fabbio Inducted into the Austin Technology Council Hall of Fame
- Cybersecurity is Protecting Your Personal Information and Your Portfolio
- L2 Aviation Celebrates Grand Opening of New Facility at Cincinnati/Northern Kentucky International Airport (CVG)
- Spokane: Flags Lowered for Justice Owens
- Managing Summer Staffing Surges with Confidence: Why Name Badges Are a Must for Seasonal Success
- Visa Named Title Sponsor of Ascending Athletes' Business Owners Summits for NFL Entrepreneurs
- Space Resources Company Interlune Unveils Full-Scale Prototype of Excavator for Harvesting Helium-3 from the Moon
- The Paris Court of International Arbitration Elects Dr. John J. Maalouf as its New President
- $56.7 Million Announced in Q1 2025 with Revenue Growth and Progress Toward NASDAQ Uplisting for AI Marketing Company: IQSTEL, Inc. Stock Symbol: IQSTD
- SAVVY MINING raised $500 million and launched BTC.XRP.DOGE cloud mining, increasing investors' returns by 30%
- New National Nonprofit Launches to Capture Firsthand Accounts of Adoption Stories
- The Tide Project Opens at Biennale Architettura 2025 in Venice Amplifying Youth Voices
- Wall Street analysts say BTC.XRP.DOGE cloud mining company SIX MINING is expected to achieve a 5-fold increase, allowing users to easily mine BTC
- Gen X Takes The Reins: New Book Guides Caregivers Juggling Parents, Kids, And Grandkids With Humor And Heart
- Fray Fitness Launches Memorial Day Sale and Veteran Organization Giveaway
- ABM for Good™ Launches First Project with Build Change
- Lucky Envelope Brewing hosts My Name Story Exhibit by Judy Lee
- ImagineX, in Collaboration with Qualys, Launches New mROC Services to Transform Enterprise Cyber Risk Management
- Ditch Micromanagement: New Leadership Book for Results-Driven, Accountability-Based Teams
- Jay Tapp was named Managing Director in British Columbia